| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917939 | Radiotherapy and Oncology | 2015 | 8 Pages |
Abstract
Compared with pCR, 2yDFS is a stronger predictor of OS. To adapt treatment most efficiently, accurate prediction models should be developed for pCR to select patients for organ preservation and for 2yDFS to select patients for more intensified treatment strategies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Vincenzo Valentini, Ruud G.P.M. van Stiphout, Guido Lammering, Maria A. Gambacorta, Maria C. Barba, Marek Bebenek, Franck Bonnetain, Jean F. Bosset, Krzysztof Bujko, Luca Cionini, Jean P. Gerard, Claus Rödel, Aldo Sainato, Rolf Sauer, Bruce D. Minsky,